|
|
||||||||


*
Roche Milano Ricerche, Milan, Italy; and
Department of Biology, Pharmacia & Upjohn, Nerviano, Milan, Italy
The insulinoma-associated protein 2 (IA-2) is a phosphatase-like
autoantigen inducing T and B cell responses associated with human
insulin-dependent diabetes mellitus (IDDM). We now report that T cell
responses to IA-2 can also be detected in the nonobese diabetic (NOD)
mouse, a model of human IDDM. Cytokine secretion in response to
purified mouse rIA-2, characterized by high IFN-
and relatively low
IL-10 and IL-6 secretion, was elicited in spleen cells from unprimed
NOD mice. Conversely, no response to IA-2 was induced in spleen cells
from BALB/c, C57BL/6, or Biozzi AB/H mice that express, like NOD, the
I-Ag7 class II molecule, but are not susceptible to
spontaneous IDDM. The IA-2-induced IFN-
response in NOD spleen cells
could already be detected at 3 wk and peaked at 8 wk of age, whereas
the IL-10 secretion was maximal at 4 wk of age and then waned.
IA-2-dependent IFN-
secretion was induced in CD4+ cells
from spleen as well as pancreatic and mesenteric lymph nodes. It
required Ag presentation by I-Ag7 molecules and engagement
of the CD4 coreceptor. Interestingly, cytokines were produced in the
absence of cell proliferation and IL-2 secretion. The biological
relevance of the response to IA-2 is indicated by the enhanced IDDM
following a single injection of the recombinant protein emulsified in
IFA into 18-day-old NOD mice. In addition, IFN-
production in
response to IA-2 and IDDM acceleration could be induced by IL-12
administration to 12-day-old NOD mice. These results identify IA-2 as
an early T cell-inducing autoantigen in the NOD mouse and indicate a
role for the IA-2-induced Th1 cell response in IDDM
pathogenesis.
This article has been cited by other articles:
![]() |
G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, N. Giarratana, E. De Carli, B. Fibbi, and L. Adorini Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse J. Immunol., August 1, 2007; 179(3): 1559 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol J. Immunol., December 15, 2006; 177(12): 8504 - 8511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Durai, H. R. Kim, and K. D. Moudgil The Regulatory C-Terminal Determinants within Mycobacterial Heat Shock Protein 65 Are Cryptic and Cross-Reactive with the Dominant Self Homologs: Implications for the Pathogenesis of Autoimmune Arthritis J. Immunol., July 1, 2004; 173(1): 181 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-{gamma}-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-{gamma} J. Immunol., June 1, 2003; 170(11): 5491 - 5501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, A. P. Olcott, and D. L. Kaufman Antigen-Based Immunotherapy Drives the Precocious Development of Autoimmunity J. Immunol., December 1, 2002; 169(11): 6564 - 6569. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Halbout, J.-P. Briand, C. Becourt, S. Muller, and C. Boitard T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse J. Immunol., September 1, 2002; 169(5): 2436 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1{alpha},25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice Diabetes, May 1, 2002; 51(5): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Winer, I. Astsaturov, R. Gaedigk, D. Hammond-McKibben, M. Pilon, A. Song, V. Kubiak, W. Karges, E. Arpaia, C. McKerlie, et al. ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide J. Immunol., January 1, 2002; 168(1): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Trembleau, S. Gregori, G. Penna, I. Gorny, and L. Adorini IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule J. Immunol., October 1, 2001; 167(7): 4104 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gregori, M. Casorati, S. Amuchastegui, S. Smiroldo, A. M. Davalli, and L. Adorini Regulatory T Cells Induced by 1{alpha},25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance J. Immunol., August 15, 2001; 167(4): 1945 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, S. Gregori, L. Adorini, and D. L. Kaufman The Frequency of High Avidity T Cells Determines the Hierarchy of Determinant Spreading J. Immunol., June 15, 2001; 166(12): 7144 - 7150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |